Standex price target raised to $286 from $260 at Roth Capital

Roth Capital raised the firm’s price target on Standex (SXI) to $286 from $260 and keeps a Buy rating on the shares. The company delivered a sound Q2, highlighted by growth and adjusted EBIT margin expansion in key segments Electronics and ETG, the analyst tells investors in a research note. The firm’s estimates are slightly higher, noting an improving balance sheet, along with a more-stable macro backdrop that likely make more portfolio optimization likely ahead, Roth added.